RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
  Bone Cancer
  Breast Cancer
  Cervical Cancer
  Gastric Cancer
  Liver Cancer
  Nerve Tissue
  Ovarian Cancer
  Pancreatic Cancer
  Prostate Cancer
  Rectal Cancer
  Renal Cell Carcinoma
  Risk Factors
  Testicular Cancer
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Vaccination Channel

subscribe to Vaccination newsletter
Latest Research : Cancer : Therapy : Vaccination

   EMAIL   |   PRINT
Use of iNKT cells boosts tumor vaccination strategy

Dec 16, 2004 - 5:51:00 PM

[RxPG] T cell responses to natural infection are orders of magnitude greater than those observed in cancer patients in response to current vaccination protocols. Optimizing tumor vaccination protocols will require a deeper understanding of the signals that the immune system coordinates in order to respond to pathogenic infection. In the December 15 issue of the Journal of Clinical Investigation, Vincenzo Cerundolo and colleagues from the University of Oxford report a vaccination approach in mice in which intravenous delivery of a protein antigen plus a type of NK T cells, known as iNKT cells, enhanced the immune response and cleared an established tumor.

The authors demonstrate that the approach is effective when the vaccine is delivered orally or intravenously and could be exploited in future vaccination protocols aimed at eliciting immune responses against cancer and infectious diseases.

Publication: December 15 issue of the Journal of Clinical Investigation
On the web: TITLE: Utilizing the adjuvant properties of Cd1d-dependent NK T cells in T cell–mediated immunotherapy 

Advertise in this space for $10 per month. Contact us today.

Related Vaccination News
First ever shots of the cervical cancer vaccine administered in Queensland
Scientists one step closer to cancer vaccine
Response to Cancer Vaccine Enhanced by Chemotherapy
Ligand Treatment of Treg Cells Enhanced Anti-Tumor Immunity
Prostate Cancer Vaccine gets Special Protocol Assessment by FDA
A Vaccine For Carcinoma Cervix
Use of iNKT cells boosts tumor vaccination strategy
First integrated immune cell response promises hope in cancer vaccine research

Subscribe to Vaccination Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)